IMP A SDB Stock Overview
Implantica AG researches, develops, commercializes, and sells medical implants in Switzerland.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Implantica AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr27.45 |
| 52 Week High | kr33.00 |
| 52 Week Low | kr15.40 |
| Beta | 1.27 |
| 1 Month Change | -4.52% |
| 3 Month Change | -1.08% |
| 1 Year Change | 45.24% |
| 3 Year Change | -75.84% |
| 5 Year Change | n/a |
| Change since IPO | -71.57% |
Recent News & Updates
Recent updates
We're Hopeful That Implantica (STO:IMP A SDB) Will Use Its Cash Wisely
Jul 26
We're Hopeful That Implantica (STO:IMP A SDB) Will Use Its Cash Wisely
Mar 06We Think Implantica (STO:IMP A SDB) Can Easily Afford To Drive Business Growth
Aug 19We Think Implantica (STO:IMP A SDB) Can Easily Afford To Drive Business Growth
May 05We're Not Very Worried About Implantica's (STO:IMP A SDB) Cash Burn Rate
Jan 14We're Hopeful That Implantica (STO:IMP A SDB) Will Use Its Cash Wisely
Sep 26Implantica (STO:IMP A SDB) Is In A Strong Position To Grow Its Business
Jan 08
Shareholder Returns
| IMP A SDB | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | -4.2% | 3.3% | -0.7% |
| 1Y | 45.2% | -61.4% | 4.4% |
Price Volatility
| IMP A SDB volatility | |
|---|---|
| IMP A SDB Average Weekly Movement | 7.2% |
| Medical Equipment Industry Average Movement | 7.2% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in SE Market | 13.1% |
| 10% least volatile stocks in SE Market | 3.5% |
Stable Share Price: IMP A SDB has not had significant price volatility in the past 3 months.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | 38 | Peter Forsell | www.implantica.com |
Implantica AG researches, develops, commercializes, and sells medical implants in Switzerland. Its lead product candidate is RefluxStop, a passive CE-marked implant for prevention of gastroesophageal reflux disease. The company also develops e-InVivo, a sensor implants to monitor a multitude of health parameters and provide diagnostic information, as well as control treatment from inside the body; wireless energizing platform; and AppetiteControl, an implant to treat obesity by controlling appetite.
Implantica AG Fundamentals Summary
| IMP A SDB fundamental statistics | |
|---|---|
| Market cap | kr7.77b |
| Earnings (TTM) | -kr277.31m |
| Revenue (TTM) | kr16.44m |
472.6x
P/S Ratio-28.0x
P/E RatioIs IMP A SDB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IMP A SDB income statement (TTM) | |
|---|---|
| Revenue | €1.41m |
| Cost of Revenue | €1.32m |
| Gross Profit | €91.00k |
| Other Expenses | €23.84m |
| Earnings | -€23.74m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 26, 2024
| Earnings per share (EPS) | -0.084 |
| Gross Margin | 6.46% |
| Net Profit Margin | -1,686.36% |
| Debt/Equity Ratio | 0% |
How did IMP A SDB perform over the long term?
See historical performance and comparison